Trials / Completed
CompletedNCT01689090
Diameter Changes of Retinal Vessels During Hypoxia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The primary objective is to study if an inhibition of nitric oxide and/or prostaglandins affect the diameter changes of retinal vessels observed during hypoxia. Diameter changes are studied using the Dynamic Vessel Analyzer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | COX inhibitor | Administration of 1 drop voltaren 45 minutes before recordings of diameter changes of retinal vessels are initiated |
| OTHER | L-NG-monomethyl arginine citrate | Intravenous administration of L-NMMA during recordings of diameter changes of retinal vessels |
| OTHER | COX inhibitor + L-NG-monomethyl arginine citrate | Combination of interventions. Administration of an eye drop voltaren and 45 minutes later infusion with L-NMMA is started and recording of diameter changes of retinal vessels is performed |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2012-09-20
- Last updated
- 2018-10-16
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01689090. Inclusion in this directory is not an endorsement.